Factors such as rise in R&D expenditure, growth of biopharmaceutical industry, and increasing government support for pharmaceutical and biotechnology industry are driving the growth of virus filtration market.
The Virus Filtration Market is expected to reach USD 3.25 billion by 2020 from USD 1.82 billion in 2015, at a CAGR of 12.3%.
Download PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157281944
The products segments included in the market are kits and reagents, filtration systems, other products and services.
Of these, the kits and reagents product segment accounted for the largest share of the global virus filtration market in 2015. High growth in kits and reagents market is attributed to the rise in R&D expenditure, growth of biopharmaceutical industry and rental agreements for reagents.
The application segments included in this report is biologicals, medical devices, water purification, and air purification. The biologicals segment is further classified into, vaccines and therapeutics, blood and blood products, cellular and gene therapy products, tissue and tissue products and stem cell products.
On the basis of end user segments this report is classified into, pharmaceutical & biotechnology companies, contract research organizations, academic research institutes and medical devices companies.
The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW). The North America region includes U.S. and Canada. Asian regional segment includes China, Japan, India and RoA.
Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=157281944
The virus filtration market is highly competitive with the presence of several small and big players. Some of the players in the virus filtration market include Merck & Co., Inc. (US), General Electric Company (US), Thermo Fisher Scientific Inc. (US), Lonza Group Ltd. (Switzerland), and Pall Corporation (US), Charles River Laboratories International, Inc. (US), Sigma-Aldrich Corporation (US), Sartorius AG (Germany), Asahi Kasei Medical Co., Ltd. (Japan) and Wuxi PharmaTech (Cayman) Inc. (China).
